$QCOR News Questcor raises quarterly dividend 20% 12:32

New Post Public Reply Private Reply Replies (0) Message Board

Jan 24, 2014 at 9:24 PM

$QCOR News

Questcor raises quarterly dividend 20% 12:32 p.m. Oct. 10, 2013 - MarketWatch.com
Hedge funds: Great with small caps, not shorts 11:50 a.m. Aug. 28, 2013 - The Trading Deck
Short sellers suffer worst losses in a decade 8:01 a.m. Aug. 21, 2013 - Insider Monkey
Small caps smoke bigger peers, but be careful 10:02 a.m. Aug. 8, 2013 - William L. Watts
7 gut checks before the stock market opens 6:22 a.m. Aug. 8, 2013 - Barbara Kollmeyer
In focus: Bears have another chance 8:09 p.m. Aug. 7, 2013 - Lawrence G. McMillan
U.S. benchmarks hold tightly to record territory 9:58 a.m. July 15, 2013 - Michael Ashbaugh
5 stocks insiders are betting on 11:15 a.m. June 25, 2013 - Insider Monkey
10 big short squeezes besides Tesla 1:32 p.m. May 22, 2013 - Wallace Witkowski
Charting a persistent May uptrend 10:57 a.m. May 21, 2013 - Michael Ashbaugh
Dow rattles cage on uncharted territory 9:47 a.m. March 20, 2013 - Michael Ashbaugh
Mellanox shares drop on lowered outlook 5:55 p.m. Jan. 2, 2013 - Wallace Witkowski
Thursday’s biggest gaining and declining stocks 4:54 p.m. Dec. 27, 2012 - Wallace Witkowski
'Fiscal cliff' accelerating dividend payments 12:18 p.m. Dec. 4, 2012 - MarketWatch.com
Questcor unveils new dividend, ups share buyback 10:23 a.m. Sept. 28, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 5:42 p.m. Sept. 25, 2012 - Greg Morcroft
Questcor price targets slashed again 4:42 p.m. Sept. 24, 2012 - blogs.marketwatch.com
U.S. probing Questcor promotional practices 7:14 a.m. Sept. 24, 2012 - MarketWatch.com
Questcor says U.S. probing co: reports 7:08 a.m. Sept. 24, 2012 - Greg Morcroft
Questcor shares fall 22% in preopen 7:02 a.m. Sept. 24, 2012 - Greg Morcroft

Questcor Pharmaceuticals (QCOR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Today - Zacks.com
3 Biotechs to Buy and 1 to Sell Now 5:29 a.m. Today - InvestorPlace.com
Retrophin - A Peak Under The Veneer Of 2 Recent Additions 6:27 p.m. Jan. 23, 2014 - Seeking Alpha
Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Health Care Winner 5:00 p.m. Jan. 23, 2014 - TheStreet.com
Tech, Health Care Lead Early Strength In Weekly Review 4:48 p.m. Jan. 23, 2014 - Investors Business Daily
Ventrus Biosciences (VTUS) Jumps: Stock Rises 10.9% - Tale of the Tape 9:46 a.m. Jan. 23, 2014 - Zacks.com
First Week Of March 22nd Options Trading For Questcor Pharmaceuticals (QCOR) 12:07 p.m. Jan. 22, 2014 - TheStreet.com
Why Investors Are Shrugging Off Amag Pharma's Feraheme FDA Rejection 11:54 a.m. Jan. 22, 2014 - TheStreet.com
Under Obamacare, Risks Grow for High-Margin Drug Stocks 5:45 a.m. Jan. 22, 2014 - InvestorPlace.com
Shire Sells Dermagraft - Analyst Blog 4:55 p.m. Jan. 20, 2014 - Zacks.com
Questcor Presents at JPM Conference - Analyst Blog 6:34 p.m. Jan. 17, 2014 - Zacks.com
ArQule Up on Study Results - Analyst Blog 6:04 p.m. Jan. 17, 2014 - Zacks.com
3 Biotech Stocks Where Momentum is Alive and Well 8:47 a.m. Jan. 17, 2014 - InvestorPlace.com
Questcor Pharmaceuticals (QCOR) Looks Good: Stock Surges 11.2% in Session - Tale of the Tape 8:44 a.m. Jan. 17, 2014 - Zacks.com
Questcor Pharmaceuticals' CEO Presents at 32nd Annual J.P. Morgan Healthcare Conference (Transcript) 2:34 p.m. Jan. 16, 2014 - Seeking Alpha
Solid 2014 Expected for Shire - Analyst Blog 2:11 p.m. Jan. 16, 2014 - Zacks.com
Questcor CEO Updates Q4, Hints At Radical Change 1:31 p.m. Jan. 16, 2014 - Investors Business Daily
Should You Worry About the Short Interest in Questcor Pharma (QCOR)? - Tale of the Tape 6:47 a.m. Jan. 16, 2014 - Zacks.com
Tomorrow's Ex-Dividends To Watch: DHY, EDI, TK, QCOR 10:00 a.m. Jan. 14, 2014 - TheStreet.com
Questcor: Continued Strong Earnings Will Drive It Over $90 - Part II 3:39 a.m. Jan. 14, 2014 - Seeking Alpha

Questcor Commits $500,000 to Launch of Questcor Research Fellowship Program for 2014 7:00 a.m. Jan. 22, 2014 - PR Newswire - PRF
Critical Alerts For SolarCity, QualComm, Questcor Pharmaceuticals, Dollar General, and Organovo Released By InvestorsObserver 9:31 a.m. Jan. 17, 2014 - PR Newswire - PRF
Questcor Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference 6:30 a.m. Jan. 8, 2014 - PR Newswire
Pre-Market Highlight of the Day: Questcor Pharma, PDL BioPharma, Amgen, and BioCryst Pharma 8:00 a.m. Jan. 3, 2014 - PR Newswire
Completed Purchases, Ratings Upgrade, Results Presentation, Dividend Declaration, and Conference Participation - Research Report on NHI, HTA, AmerisourceBergen, Questcor, and Thoratec 8:00 a.m. Dec. 31, 2013 - PR Newswire
Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana 8:00 a.m. Dec. 20, 2013 - PR Newswire
Important Trend Analysis: Tesla Motors Inc, Federal National Mortgage Association, WPCS International Incorporated, Questcor Pharmaceuticals Inc 11:16 a.m. Dec. 19, 2013 - ACCESSWIRE
Notable Buzzers: Questcor Pharmaceuticals, Omeros Corporation, BioCryst Pharmaceuticals, Baidu Inc 10:36 a.m. Dec. 18, 2013 - ACCESSWIRE
Questcor Provides Donation In Support Of Children's Hospital & Research Center Oakland 4:00 p.m. Dec. 17, 2013 - PR Newswire
Partnerships, Appointments, New Products, Public Offerings, and Agreements - Research Report on Questcor Pharmaceuticals, Hologic, IDEXX, Endologix, and Healthways 8:00 a.m. Dec. 13, 2013 - PR Newswire
Questcor Announces Quarterly Cash Dividend and Provides Update on Share Repurchase Program 7:00 a.m. Dec. 11, 2013 - PR Newswire
Questcor and Child Neurology Foundation Support the 5th Annual Infantile Spasms Awareness Week 6:30 a.m. Dec. 9, 2013 - PR Newswire
Questcor Pharmaceuticals to Present at the Oppenheimer Annual Healthcare Conference 5:56 p.m. Dec. 5, 2013 - PR Newswire
Biologics License Applications, Event Participations, and Stock Movements - Research Report on Baxter, WellPoint, Questcor Pharmaceuticals, CareFusion, and Hologic 8:00 a.m. Dec. 5, 2013 - PR Newswire
Product Reviews, Recognitions, FDA Responses, and New Leadership Appointments - Research Report on Gilead, WellPoint, Questcor, Forest Laboratories, and Envision Healthcare 8:00 a.m. Nov. 27, 2013 - PR Newswire
Questcor Honored as an "Everyday Hero" by NephCure Foundation 7:00 a.m. Nov. 22, 2013 - PR Newswire
Biotech Companies Announce Upcoming Conferences, Appointments - Research Report on Illumina, Epizyme, Questcor Pharmaceuticals, Infinity, and Endocyte 8:00 a.m. Nov. 19, 2013 - PR Newswire
Questcor Adds G. Kelly Martin to Board of Directors 4:25 p.m. Nov. 12, 2013 - PR Newswire
New Appointments, Financial Results, Dividends, and Presentations - Research Report on WellPoint, Perrigo, Health Net, Zoetis, and Questcor 8:00 a.m. Nov. 12, 2013 - PR Newswire
Before the Bell Scans: PDL BioPharma Inc., Amgen Inc., Questcor Pharma Inc., and BioCryst Pharma Inc. 12:24 p.m. Nov. 8, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...